SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5df0'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AXW_A_MTXA732_1 (THYMIDYLATE SYNTHASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	6 / 12	HIS A 176 ILE A 429 PHE A 377 TYR A 435 VAL A 432 ALA A 433	None	1.49A	1axwA-5df0A: undetectable	1axwA-5df0A: 18.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DIT_P_2PPP1_1 (ALPHA-THROMBIN PEPTIDE INHIBITOR CVS995)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 6	LEU A 522 ILE A 376 ASP A 424 PRO A 425	None	1.23A	1ditH-5df0A: undetectable 1ditP-5df0A: undetectable	1ditH-5df0A: 17.85 1ditP-5df0A: 3.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E9L_A_GCSA800_1 (YM1 SECRETORY PROTEIN)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	6 / 9	TYR A 153 PHE A 181 GLY A 264 ASP A 303 ASP A 382 TRP A 528	58Y A 605 (-3.6A) 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) None 58Y A 605 ( 3.0A) 58Y A 605 (-3.7A)	1.07A	1e9lA-5df0A: 42.1	1e9lA-5df0A: 20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E9L_A_GCSA800_1 (YM1 SECRETORY PROTEIN)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	7 / 9	TYR A 153 PHE A 181 GLY A 264 ASP A 303 MET A 379 TYR A 381 ASP A 382	58Y A 605 (-3.6A) 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) None 58Y A 605 (-3.3A) 58Y A 605 (-4.9A) 58Y A 605 ( 3.0A)	0.82A	1e9lA-5df0A: 42.1	1e9lA-5df0A: 20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q23_C_FUAC701_2 (CHLORAMPHENICOL ACETYLTRANSFERASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 12	THR A 124 PHE A 297 PHE A 243 LEU A 46 VAL A 225	None	1.28A	1q23C-5df0A: undetectable	1q23C-5df0A: 17.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q23_F_FUAF704_1 (CHLORAMPHENICOL ACETYLTRANSFERASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 11	THR A 124 PHE A 297 PHE A 243 LEU A 46 VAL A 225	None	1.25A	1q23F-5df0A: undetectable	1q23F-5df0A: 17.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q23_I_FUAI707_2 (CHLORAMPHENICOL ACETYLTRANSFERASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 11	THR A 124 PHE A 297 PHE A 243 LEU A 46 VAL A 225	None	1.24A	1q23I-5df0A: undetectable	1q23I-5df0A: 17.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RU9_H_BEZH601_0 (IMMUNOGLOBULIN IGG2A, HEAVY CHAIN IMMUNOGLOBULIN IGG2A, LIGHT CHAIN)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 9	ALA A 70 TYR A 71 LEU A 105 GLY A 67 GLY A 110	None	1.32A	1ru9H-5df0A: 8.1 1ru9L-5df0A: 7.5	1ru9H-5df0A: 17.60 1ru9L-5df0A: 16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RUA_H_BEZH601_0 (IMMUNOGLOBULIN IGG2A, HEAVY CHAIN IMMUNOGLOBULIN IGG2A, LIGHT CHAIN)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 10	ALA A 70 TYR A 71 LEU A 105 GLY A 67 GLY A 110	None	1.31A	1ruaH-5df0A: 8.2 1ruaL-5df0A: 4.7	1ruaH-5df0A: 17.60 1ruaL-5df0A: 16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RUL_H_BEZH601_0 (IMMUNOGLOBULIN IGG2A, HEAVY CHAIN IMMUNOGLOBULIN IGG2A, LIGHT CHAIN)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 9	ALA A 70 TYR A 71 LEU A 105 GLY A 67 GLY A 110	None	1.34A	1rulH-5df0A: 8.1 1rulL-5df0A: 7.3	1rulH-5df0A: 17.60 1rulL-5df0A: 16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3A_A_TEPA1433_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	10 / 11	TYR A 153 PHE A 181 GLY A 264 ASP A 303 GLU A 305 MET A 379 TYR A 381 ASP A 382 TYR A 435 TRP A 528	58Y A 605 (-3.6A) 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) None 58Y A 605 (-3.1A) 58Y A 605 (-3.3A) 58Y A 605 (-4.9A) 58Y A 605 ( 3.0A) None 58Y A 605 (-3.7A)	0.39A	2a3aA-5df0A: 43.3	2a3aA-5df0A: 27.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3A_A_TEPA1433_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	8 / 11	TYR A 153 PHE A 181 GLY A 264 TRP A 265 ASP A 303 GLU A 305 MET A 379 TRP A 528	58Y A 605 (-3.6A) 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) NAG A 603 ( 3.9A) None 58Y A 605 (-3.1A) 58Y A 605 (-3.3A) 58Y A 605 (-3.7A)	0.64A	2a3aA-5df0A: 43.3	2a3aA-5df0A: 27.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3A_B_TEPB2433_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	8 / 9	PHE A 181 GLY A 264 GLU A 305 MET A 379 TYR A 381 ASP A 382 TYR A 435 TRP A 528	58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) 58Y A 605 (-3.1A) 58Y A 605 (-3.3A) 58Y A 605 (-4.9A) 58Y A 605 ( 3.0A) None 58Y A 605 (-3.7A)	0.38A	2a3aB-5df0A: 43.4	2a3aB-5df0A: 27.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1435_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	7 / 11	PHE A 181 GLY A 264 TRP A 265 ASP A 303 GLU A 305 TYR A 381 TRP A 528	58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) NAG A 603 ( 3.9A) None 58Y A 605 (-3.1A) 58Y A 605 (-4.9A) 58Y A 605 (-3.7A)	0.85A	2a3bA-5df0A: 43.3	2a3bA-5df0A: 27.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1435_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	8 / 11	PHE A 181 GLY A 264 TRP A 265 ASP A 303 TYR A 381 ASP A 382 TYR A 435 TRP A 528	58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) NAG A 603 ( 3.9A) None 58Y A 605 (-4.9A) 58Y A 605 ( 3.0A) None 58Y A 605 (-3.7A)	0.61A	2a3bA-5df0A: 43.3	2a3bA-5df0A: 27.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1435_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	8 / 11	TYR A 153 PHE A 181 GLY A 264 ASP A 303 GLU A 305 MET A 379 TYR A 381 TRP A 528	58Y A 605 (-3.6A) 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) None 58Y A 605 (-3.1A) 58Y A 605 (-3.3A) 58Y A 605 (-4.9A) 58Y A 605 (-3.7A)	0.69A	2a3bA-5df0A: 43.3	2a3bA-5df0A: 27.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_A_CFFA1435_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	9 / 11	TYR A 153 PHE A 181 GLY A 264 ASP A 303 MET A 379 TYR A 381 ASP A 382 TYR A 435 TRP A 528	58Y A 605 (-3.6A) 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) None 58Y A 605 (-3.3A) 58Y A 605 (-4.9A) 58Y A 605 ( 3.0A) None 58Y A 605 (-3.7A)	0.39A	2a3bA-5df0A: 43.3	2a3bA-5df0A: 27.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3B_B_CFFB2435_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	9 / 10	PHE A 181 GLY A 264 ASP A 303 GLU A 305 MET A 379 TYR A 381 ASP A 382 TYR A 435 TRP A 528	58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) None 58Y A 605 (-3.1A) 58Y A 605 (-3.3A) 58Y A 605 (-4.9A) 58Y A 605 ( 3.0A) None 58Y A 605 (-3.7A)	0.63A	2a3bB-5df0A: 12.2	2a3bB-5df0A: 27.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3C_A_PNXA1434_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	9 / 12	TYR A 153 TRP A 157 PHE A 181 GLY A 264 ASP A 303 GLU A 305 MET A 379 TYR A 381 TRP A 528	58Y A 605 (-3.6A) None 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) None 58Y A 605 (-3.1A) 58Y A 605 (-3.3A) 58Y A 605 (-4.9A) 58Y A 605 (-3.7A)	0.69A	2a3cA-5df0A: 12.2	2a3cA-5df0A: 27.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3C_A_PNXA1434_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	10 / 12	TYR A 153 TRP A 157 PHE A 181 GLY A 264 ASP A 303 MET A 379 TYR A 381 ASP A 382 TYR A 435 TRP A 528	58Y A 605 (-3.6A) None 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) None 58Y A 605 (-3.3A) 58Y A 605 (-4.9A) 58Y A 605 ( 3.0A) None 58Y A 605 (-3.7A)	0.41A	2a3cA-5df0A: 12.2	2a3cA-5df0A: 27.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3C_B_PNXB2433_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	11 / 12	TRP A 157 PHE A 181 GLY A 264 THR A 266 ASP A 303 GLU A 305 MET A 379 TYR A 381 ASP A 382 TYR A 435 TRP A 528	None 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) SN5 A 604 (-3.1A) None 58Y A 605 (-3.1A) 58Y A 605 (-3.3A) 58Y A 605 (-4.9A) 58Y A 605 ( 3.0A) None 58Y A 605 (-3.7A)	0.65A	2a3cB-5df0A: 43.4	2a3cB-5df0A: 27.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOU_A_CQAA403_0 (HISTAMINE N-METHYLTRANSFERASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 8	LYS A 240 GLY A 244 PHE A 296 ASP A 123	None	0.95A	2aouA-5df0A: undetectable	2aouA-5df0A: 19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOU_A_CQAA403_0 (HISTAMINE N-METHYLTRANSFERASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 8	LYS A 240 GLY A 244 PHE A 296 ASP A 125	None	0.93A	2aouA-5df0A: undetectable	2aouA-5df0A: 19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKJ_D_CLMD1142_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 5	PRO A 270 PRO A 183 ILE A 182 GLY A 263	None	1.08A	2jkjD-5df0A: undetectable	2jkjD-5df0A: 14.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKJ_F_CLMF1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 5	PRO A 270 PRO A 183 ILE A 182 GLY A 263	None	1.08A	2jkjF-5df0A: undetectable	2jkjF-5df0A: 14.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QHF_A_ACTA509_0 (CHORISMATE SYNTHASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	3 / 3	ARG A 206 GLN A 226 PRO A 221	None	0.89A	2qhfA-5df0A: undetectable	2qhfA-5df0A: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2UY4_A_AZMA1311_1 (ENDOCHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	6 / 9	TYR A 153 PHE A 181 GLY A 264 ASP A 303 TYR A 381 TRP A 528	58Y A 605 (-3.6A) 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) None 58Y A 605 (-4.9A) 58Y A 605 (-3.7A)	1.03A	2uy4A-5df0A: 17.5	2uy4A-5df0A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2UY4_A_AZMA1311_1 (ENDOCHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	6 / 9	TYR A 153 PHE A 181 GLY A 264 GLU A 305 TYR A 381 TRP A 528	58Y A 605 (-3.6A) 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) 58Y A 605 (-3.1A) 58Y A 605 (-4.9A) 58Y A 605 (-3.7A)	0.40A	2uy4A-5df0A: 17.5	2uy4A-5df0A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VE3_B_REAB1445_1 (PUTATIVE CYTOCHROME P450 120)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 12	PHE A 484 ALA A 527 VAL A 514 GLY A 512 GLN A 489	None	1.29A	2ve3B-5df0A: undetectable	2ve3B-5df0A: 21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VN1_A_FK5A501_2 (70 KDA PEPTIDYLPROLYL ISOMERASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 6	LEU A 256 SER A 261 ASP A 303 LYS A 257	None	1.14A	2vn1B-5df0A: undetectable	2vn1B-5df0A: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W1B_A_DXCA2034_0 (ACRIFLAVIN RESISTANCE PROTEIN B)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	3 / 3	PHE A 377 SER A 175 LEU A 177	None	0.68A	2w1bA-5df0A: undetectable	2w1bA-5df0A: 20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X45_A_HSMA1161_1 (ALLERGEN ARG R 1)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 5	VAL A 517 TYR A 516 VAL A 415 SER A 380	None	1.23A	2x45A-5df0A: undetectable	2x45A-5df0A: 11.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X45_B_HSMB1161_1 (ALLERGEN ARG R 1)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 4	VAL A 517 TYR A 516 VAL A 415 SER A 380	None	1.22A	2x45B-5df0A: undetectable	2x45B-5df0A: 11.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XCT_X_CPFX1020_1 (DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 4	ARG A 471 GLY A 535 GLU A 138 SER A 509	None	1.38A	2xctS-5df0A: undetectable 2xctU-5df0A: undetectable	2xctS-5df0A: 20.79 2xctU-5df0A: 20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XTK_A_AZMA1339_1 (CLASS III CHITINASE CHIA1)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	6 / 11	TYR A 153 PHE A 181 GLY A 264 GLU A 305 TYR A 381 TRP A 528	58Y A 605 (-3.6A) 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) 58Y A 605 (-3.1A) 58Y A 605 (-4.9A) 58Y A 605 (-3.7A)	0.72A	2xtkA-5df0A: 18.8	2xtkA-5df0A: 21.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XTK_B_AZMB1339_1 (CLASS III CHITINASE CHIA1)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 10	TYR A 153 PHE A 181 GLY A 264 ASP A 303 TYR A 381	58Y A 605 (-3.6A) 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) None 58Y A 605 (-4.9A)	1.16A	2xtkB-5df0A: 18.9	2xtkB-5df0A: 21.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XTK_B_AZMB1339_1 (CLASS III CHITINASE CHIA1)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	6 / 10	TYR A 153 PHE A 181 GLY A 264 GLU A 305 TYR A 381 TRP A 528	58Y A 605 (-3.6A) 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) 58Y A 605 (-3.1A) 58Y A 605 (-4.9A) 58Y A 605 (-3.7A)	0.52A	2xtkB-5df0A: 18.9	2xtkB-5df0A: 21.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y05_A_RALA801_1 (PROSTAGLANDIN REDUCTASE 1)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 8	VAL A 79 VAL A 119 TYR A 31 VAL A 93	None	1.02A	2y05A-5df0A: undetectable 2y05B-5df0A: undetectable	2y05A-5df0A: 21.23 2y05B-5df0A: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZZN_B_SAMB402_0 (UNCHARACTERIZED PROTEIN MJ0883)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 12	PHE A 214 PHE A 290 ILE A 190 ASP A 192 PHE A 201	None	1.34A	2zznB-5df0A: undetectable	2zznB-5df0A: 21.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ARQ_A_DM5A606_1 (CHITINASE A)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	6 / 6	TRP A 265 LYS A 360 ASP A 382 TRP A 387 TYR A 409 ARG A 437	NAG A 603 ( 3.9A) None 58Y A 605 ( 3.0A) NAG A 603 (-4.5A) None 58Y A 605 ( 3.3A)	0.79A	3arqA-5df0A: 54.0	3arqA-5df0A: 44.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ARR_A_PNXA606_1 (CHITINASE A)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	7 / 7	TRP A 265 GLY A 357 LYS A 360 ASP A 382 TRP A 387 TYR A 409 ARG A 437	NAG A 603 ( 3.9A) None None 58Y A 605 ( 3.0A) NAG A 603 (-4.5A) None 58Y A 605 ( 3.3A)	0.71A	3arrA-5df0A: 55.0	3arrA-5df0A: 44.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ARR_A_PNXA607_1 (CHITINASE A)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 7	SER A 200 HIS A 219 THR A 266 LEU A 267 TRP A 528	None None SN5 A 604 (-3.1A) None 58Y A 605 (-3.7A)	0.79A	3arrA-5df0A: 55.0	3arrA-5df0A: 44.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ARR_A_PNXA607_1 (CHITINASE A)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 7	TRP A 157 SER A 200 HIS A 219 THR A 266 LEU A 267	None None None SN5 A 604 (-3.1A) None	0.56A	3arrA-5df0A: 55.0	3arrA-5df0A: 44.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ARU_A_PNXA606_1 (CHITINASE A)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	7 / 7	PHE A 306 GLY A 357 LYS A 360 ASP A 382 TRP A 387 TYR A 409 ARG A 437	None None None 58Y A 605 ( 3.0A) NAG A 603 (-4.5A) None 58Y A 605 ( 3.3A)	0.75A	3aruA-5df0A: 54.6	3aruA-5df0A: 44.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ARU_A_PNXA608_1 (CHITINASE A)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 6	TRP A 157 SER A 200 HIS A 219 ASP A 220	None	0.44A	3aruA-5df0A: 54.6	3aruA-5df0A: 44.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CCF_B_BEZB261_0 (CYCLOPROPANE-FATTY-A CYL-PHOSPHOLIPID SYNTHASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 8	ILE A 47 TRP A 294 TYR A 43 ARG A 211	None None None SO4 A 608 (-2.7A)	1.33A	3ccfB-5df0A: undetectable	3ccfB-5df0A: 20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G6M_A_CFFA1_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	11 / 11	TYR A 153 PHE A 181 GLY A 264 TRP A 265 ASP A 303 GLU A 305 MET A 379 TYR A 381 ASP A 382 TYR A 435 TRP A 528	58Y A 605 (-3.6A) 58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) NAG A 603 ( 3.9A) None 58Y A 605 (-3.1A) 58Y A 605 (-3.3A) 58Y A 605 (-4.9A) 58Y A 605 ( 3.0A) None 58Y A 605 (-3.7A)	0.52A	3g6mA-5df0A: 12.6	3g6mA-5df0A: 28.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G6M_A_CFFA427_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 5	TRP A 265 MET A 379 ASP A 382 TRP A 387	NAG A 603 ( 3.9A) 58Y A 605 (-3.3A) 58Y A 605 ( 3.0A) NAG A 603 (-4.5A)	0.82A	3g6mA-5df0A: 12.6	3g6mA-5df0A: 28.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HS4_A_AZMA702_1 (CARBONIC ANHYDRASE 2)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 7	VAL A 225 LYS A 240 TYR A 38 TRP A 294 GLU A 35	None	1.36A	3hs4A-5df0A: undetectable	3hs4A-5df0A: 20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MB5_A_SAMA301_1 (SAM-DEPENDENT METHYLTRANSFERASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 4	GLY A 535 GLU A 138 ASP A 531 ASP A 536	None	1.15A	3mb5A-5df0A: undetectable	3mb5A-5df0A: 19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NXU_A_RITA600_1 (CYTOCHROME P450 3A4)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 12	LEU A 171 ALA A 152 ILE A 541 ALA A 540 GLY A 143	None	0.98A	3nxuA-5df0A: undetectable	3nxuA-5df0A: 22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q1E_C_T44C128_1 (5-HYDROXYISOURATE HYDROLASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 6	LEU A 171 LEU A 174 LEU A 259 LEU A 178	None	0.93A	3q1eA-5df0A: 3.4 3q1eC-5df0A: undetectable	3q1eA-5df0A: 12.55 3q1eC-5df0A: 12.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q1E_C_T44C128_1 (5-HYDROXYISOURATE HYDROLASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 6	LEU A 259 LEU A 178 LEU A 171 LEU A 174	None	0.86A	3q1eA-5df0A: 3.4 3q1eC-5df0A: undetectable	3q1eA-5df0A: 12.55 3q1eC-5df0A: 12.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SJ0_X_DXCX75_0 (CYTOCHROME C7)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 7	ILE A 182 PHE A 296 MET A 247 GLY A 244	None	1.10A	3sj0X-5df0A: undetectable	3sj0X-5df0A: 11.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3O_B_T1CB405_1 (TETX2 PROTEIN)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 12	PHE A 306 ASN A 313 GLY A 309 GLY A 263 MET A 379	None None None None 58Y A 605 (-3.3A)	1.18A	3v3oB-5df0A: undetectable	3v3oB-5df0A: 21.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V8V_B_SAMB801_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE L)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 11	ASP A 533 ASP A 536 ASP A 505 VAL A 432 ASN A 173	None	1.26A	3v8vB-5df0A: undetectable	3v8vB-5df0A: 22.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WQV_A_GCSA501_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 11	PHE A 181 GLY A 264 ASP A 303 TYR A 381 TRP A 528	58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) None 58Y A 605 (-4.9A) 58Y A 605 (-3.7A)	0.97A	3wqvA-5df0A: 42.2	3wqvA-5df0A: 25.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WQV_A_GCSA501_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	10 / 11	PHE A 181 GLY A 264 TRP A 265 GLU A 305 MET A 379 TYR A 381 ASP A 382 TYR A 435 ARG A 437 TRP A 528	58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) NAG A 603 ( 3.9A) 58Y A 605 (-3.1A) 58Y A 605 (-3.3A) 58Y A 605 (-4.9A) 58Y A 605 ( 3.0A) None 58Y A 605 ( 3.3A) 58Y A 605 (-3.7A)	0.52A	3wqvA-5df0A: 42.2	3wqvA-5df0A: 25.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WQW_A_GCSA501_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 11	PHE A 181 GLY A 264 ASP A 303 TYR A 381 TRP A 528	58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) None 58Y A 605 (-4.9A) 58Y A 605 (-3.7A)	0.99A	3wqwA-5df0A: 42.2	3wqwA-5df0A: 25.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WQW_A_GCSA501_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	10 / 11	PHE A 181 GLY A 264 TRP A 265 GLU A 305 MET A 379 TYR A 381 ASP A 382 TYR A 435 ARG A 437 TRP A 528	58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) NAG A 603 ( 3.9A) 58Y A 605 (-3.1A) 58Y A 605 (-3.3A) 58Y A 605 (-4.9A) 58Y A 605 ( 3.0A) None 58Y A 605 ( 3.3A) 58Y A 605 (-3.7A)	0.56A	3wqwA-5df0A: 42.2	3wqwA-5df0A: 25.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGK_A_0TXA302_0 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 6	PHE A 283 ILE A 182 PRO A 183 PHE A 271	None	1.04A	4fgkA-5df0A: undetectable	4fgkA-5df0A: 17.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J4V_B_SVRB301_1 (NUCLEOCAPSID PROTEIN)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 10	GLY A 461 ARG A 162 ALA A 532 VAL A 468 PRO A 458	None	1.36A	4j4vB-5df0A: 0.4	4j4vB-5df0A: 18.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LRH_B_FOLB301_1 (FOLATE RECEPTOR ALPHA)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	3 / 3	ASP A 359 TRP A 265 SER A 355	None NAG A 603 ( 3.9A) None	0.89A	4lrhB-5df0A: undetectable	4lrhB-5df0A: 17.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LRH_F_FOLF301_1 (FOLATE RECEPTOR ALPHA)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	3 / 3	ASP A 359 TRP A 265 SER A 355	None NAG A 603 ( 3.9A) None	0.86A	4lrhF-5df0A: undetectable	4lrhF-5df0A: 17.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N09_B_ADNB401_2 (ADENOSINE KINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 5	LEU A 171 SER A 175 LEU A 538 ASN A 542	None	1.04A	4n09B-5df0A: 4.0	4n09B-5df0A: 22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N09_C_ADNC401_2 (ADENOSINE KINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 5	LEU A 171 SER A 175 LEU A 538 ASN A 542	None	1.03A	4n09C-5df0A: undetectable	4n09C-5df0A: 22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WBO_B_ANWB601_0 (RHODOPSIN KINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 8	LEU A 177 ALA A 152 ILE A 530 ALA A 249	None	0.69A	4wboB-5df0A: undetectable	4wboB-5df0A: 22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XNX_A_41XA707_1 (TRANSPORTER)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 11	ASP A 359 ALA A 323 VAL A 364 TYR A 366 GLY A 309	None	1.07A	4xnxA-5df0A: undetectable	4xnxA-5df0A: 21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP9_C_1WEC706_1 (TRANSPORTER)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 4	PHE A 181 ASP A 301 GLY A 264 SER A 261	58Y A 605 (-4.5A) None 58Y A 605 ( 4.2A) None	1.41A	4xp9C-5df0A: undetectable	4xp9C-5df0A: 21.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EF8_B_LBHB2004_1 (HDAC6 PROTEIN)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 12	ASP A 188 HIS A 275 PHE A 273 ASP A 322 LEU A 316	None	1.42A	5ef8B-5df0A: undetectable	5ef8B-5df0A: 20.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GQB_A_GCSA602_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	3 / 3	TRP A 265 GLU A 305 ASP A 382	NAG A 603 ( 3.9A) 58Y A 605 (-3.1A) 58Y A 605 ( 3.0A)	0.17A	5gqbA-5df0A: 62.6	5gqbA-5df0A: 61.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GQB_A_GCSA603_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	8 / 8	PHE A 181 GLY A 264 TRP A 265 GLU A 305 TYR A 381 ASP A 382 ARG A 437 TRP A 528	58Y A 605 (-4.5A) 58Y A 605 ( 4.2A) NAG A 603 ( 3.9A) 58Y A 605 (-3.1A) 58Y A 605 (-4.9A) 58Y A 605 ( 3.0A) 58Y A 605 ( 3.3A) 58Y A 605 (-3.7A)	0.39A	5gqbA-5df0A: 62.6	5gqbA-5df0A: 61.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GQB_A_GCSA604_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 4	TRP A 157 TRP A 265 THR A 266 LEU A 267	None NAG A 603 ( 3.9A) SN5 A 604 (-3.1A) None	0.36A	5gqbA-5df0A: 62.6	5gqbA-5df0A: 61.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5GQB_A_GCSA605_1 (CHITINASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	3 / 3	TRP A 157 ILE A 197 SER A 200	None	0.68A	5gqbA-5df0A: 62.6	5gqbA-5df0A: 61.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5K9D_A_ACTA407_0 (DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 5	ASP A 54 THR A 90 GLN A 56 ARG A 88	None SO4 A 609 (-3.8A) None None	1.32A	5k9dA-5df0A: 12.2	5k9dA-5df0A: 22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LJC_A_RTLA201_0 (RETINOL-BINDING PROTEIN 1)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 12	ALA A 369 LEU A 373 SER A 352 ILE A 361 LEU A 522	None	1.12A	5ljcA-5df0A: undetectable	5ljcA-5df0A: 15.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VOO_A_C2FA3001_0 (5-METHYLTETRAHYDROFO LATE HOMOCYSTEINE S-METHYLTRANSFERASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 12	GLU A 529 ARG A 162 GLY A 158 LEU A 256 ILE A 530	SN5 A 604 (-3.9A) None None None None	1.16A	5vooA-5df0A: 3.1	5vooA-5df0A: 21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VOO_C_C2FC702_0 (5-METHYLTETRAHYDROFO LATE HOMOCYSTEINE S-METHYLTRANSFERASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 12	GLU A 529 ARG A 162 GLY A 158 LEU A 256 ILE A 530	SN5 A 604 (-3.9A) None None None None	1.14A	5vooC-5df0A: 4.2	5vooC-5df0A: 21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWN_C_AQ4C602_1 (CYTOCHROME P450 1A1)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	3 / 3	SER A 207 SER A 203 ALA A 223	None	0.52A	6dwnC-5df0A: undetectable	6dwnC-5df0A: 9.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6F6S_B_CXQB705_1 (ENVELOPE GLYCOPROTEIN,ENVELOP E GLYCOPROTEIN,GP1 ENVELOPE GLYCOPROTEIN)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	4 / 6	VAL A 169 LEU A 174 LEU A 256 LEU A 178	None	0.87A	6f6sA-5df0A: undetectable 6f6sB-5df0A: undetectable	6f6sA-5df0A: 10.49 6f6sB-5df0A: 11.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6R2E_F_FFOF403_0 (THYMIDYLATE SYNTHASE)	5df0	AC-CHIA (Autographa californica multiple nucleopolyhedrov irus)	5 / 11	LEU A 174 ASP A 533 LEU A 537 GLY A 535 ALA A 527	None	1.32A	6r2eF-5df0A: undetectable	6r2eF-5df0A: 20.33

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AXW_A_MTXA732_1","THYMIDYLATE SYNTHASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",6,"HIS A 176;ILE A 429;PHE A 377;TYR A 435;VAL A 432;ALA A 433","None","1.49A","1axwA-5df0A:undetectable","1axwA-5df0A:18.08"],["1DIT_P_2PPP1_1","ALPHA-THROMBIN;PEPTIDE INHIBITOR CVS995","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"LEU A 522;ILE A 376;ASP A 424;PRO A 425","None","1.23A","1ditH-5df0A:undetectable;1ditP-5df0A:undetectable","1ditH-5df0A:17.85;1ditP-5df0A:3.90"],["1E9L_A_GCSA800_1","YM1 SECRETORY PROTEIN","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",6,"TYR A 153;PHE A 181;GLY A 264;ASP A 303;ASP A 382;TRP A 528","58Y A 605 (-3.6A);58Y A 605 (-4.5A);58Y A 605 ( 4.2A);None;58Y A 605 ( 3.0A);58Y A 605 (-3.7A)","1.07A","1e9lA-5df0A:42.1","1e9lA-5df0A:20.78"],["1E9L_A_GCSA800_1","YM1 SECRETORY PROTEIN","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",7,"TYR A 153;PHE A 181;GLY A 264;ASP A 303;MET A 379;TYR A 381;ASP A 382","58Y A 605 (-3.6A);58Y A 605 (-4.5A);58Y A 605 ( 4.2A);None;58Y A 605 (-3.3A);58Y A 605 (-4.9A);58Y A 605 ( 3.0A)","0.82A","1e9lA-5df0A:42.1","1e9lA-5df0A:20.78"],["1Q23_C_FUAC701_2","CHLORAMPHENICOL ACETYLTRANSFERASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"THR A 124;PHE A 297;PHE A 243;LEU A  46;VAL A 225","None","1.28A","1q23C-5df0A:undetectable","1q23C-5df0A:17.93"],["1Q23_F_FUAF704_1","CHLORAMPHENICOL ACETYLTRANSFERASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"THR A 124;PHE A 297;PHE A 243;LEU A  46;VAL A 225","None","1.25A","1q23F-5df0A:undetectable","1q23F-5df0A:17.93"],["1Q23_I_FUAI707_2","CHLORAMPHENICOL ACETYLTRANSFERASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"THR A 124;PHE A 297;PHE A 243;LEU A  46;VAL A 225","None","1.24A","1q23I-5df0A:undetectable","1q23I-5df0A:17.93"],["1RU9_H_BEZH601_0","IMMUNOGLOBULIN IGG2A, HEAVY CHAIN;IMMUNOGLOBULIN IGG2A, LIGHT CHAIN","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"ALA A  70;TYR A  71;LEU A 105;GLY A  67;GLY A 110","None","1.32A","1ru9H-5df0A:8.1;1ru9L-5df0A:7.5","1ru9H-5df0A:17.60;1ru9L-5df0A:16.70"],["1RUA_H_BEZH601_0","IMMUNOGLOBULIN IGG2A, HEAVY CHAIN;IMMUNOGLOBULIN IGG2A, LIGHT CHAIN","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"ALA A  70;TYR A  71;LEU A 105;GLY A  67;GLY A 110","None","1.31A","1ruaH-5df0A:8.2;1ruaL-5df0A:4.7","1ruaH-5df0A:17.60;1ruaL-5df0A:16.70"],["1RUL_H_BEZH601_0","IMMUNOGLOBULIN IGG2A, HEAVY CHAIN;IMMUNOGLOBULIN IGG2A, LIGHT CHAIN","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"ALA A  70;TYR A  71;LEU A 105;GLY A  67;GLY A 110","None","1.34A","1rulH-5df0A:8.1;1rulL-5df0A:7.3","1rulH-5df0A:17.60;1rulL-5df0A:16.70"],["2A3A_A_TEPA1433_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",10,"TYR A 153;PHE A 181;GLY A 264;ASP A 303;GLU A 305;MET A 379;TYR A 381;ASP A 382;TYR A 435;TRP A 528","58Y A 605 (-3.6A);58Y A 605 (-4.5A);58Y A 605 ( 4.2A);None;58Y A 605 (-3.1A);58Y A 605 (-3.3A);58Y A 605 (-4.9A);58Y A 605 ( 3.0A);None;58Y A 605 (-3.7A)","0.39A","2a3aA-5df0A:43.3","2a3aA-5df0A:27.63"],["2A3A_A_TEPA1433_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",8,"TYR A 153;PHE A 181;GLY A 264;TRP A 265;ASP A 303;GLU A 305;MET A 379;TRP A 528","58Y A 605 (-3.6A);58Y A 605 (-4.5A);58Y A 605 ( 4.2A);NAG A 603 ( 3.9A);None;58Y A 605 (-3.1A);58Y A 605 (-3.3A);58Y A 605 (-3.7A)","0.64A","2a3aA-5df0A:43.3","2a3aA-5df0A:27.63"],["2A3A_B_TEPB2433_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",8,"PHE A 181;GLY A 264;GLU A 305;MET A 379;TYR A 381;ASP A 382;TYR A 435;TRP A 528","58Y A 605 (-4.5A);58Y A 605 ( 4.2A);58Y A 605 (-3.1A);58Y A 605 (-3.3A);58Y A 605 (-4.9A);58Y A 605 ( 3.0A);None;58Y A 605 (-3.7A)","0.38A","2a3aB-5df0A:43.4","2a3aB-5df0A:27.63"],["2A3B_A_CFFA1435_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",7,"PHE A 181;GLY A 264;TRP A 265;ASP A 303;GLU A 305;TYR A 381;TRP A 528","58Y A 605 (-4.5A);58Y A 605 ( 4.2A);NAG A 603 ( 3.9A);None;58Y A 605 (-3.1A);58Y A 605 (-4.9A);58Y A 605 (-3.7A)","0.85A","2a3bA-5df0A:43.3","2a3bA-5df0A:27.63"],["2A3B_A_CFFA1435_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",8,"PHE A 181;GLY A 264;TRP A 265;ASP A 303;TYR A 381;ASP A 382;TYR A 435;TRP A 528","58Y A 605 (-4.5A);58Y A 605 ( 4.2A);NAG A 603 ( 3.9A);None;58Y A 605 (-4.9A);58Y A 605 ( 3.0A);None;58Y A 605 (-3.7A)","0.61A","2a3bA-5df0A:43.3","2a3bA-5df0A:27.63"],["2A3B_A_CFFA1435_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",8,"TYR A 153;PHE A 181;GLY A 264;ASP A 303;GLU A 305;MET A 379;TYR A 381;TRP A 528","58Y A 605 (-3.6A);58Y A 605 (-4.5A);58Y A 605 ( 4.2A);None;58Y A 605 (-3.1A);58Y A 605 (-3.3A);58Y A 605 (-4.9A);58Y A 605 (-3.7A)","0.69A","2a3bA-5df0A:43.3","2a3bA-5df0A:27.63"],["2A3B_A_CFFA1435_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",9,"TYR A 153;PHE A 181;GLY A 264;ASP A 303;MET A 379;TYR A 381;ASP A 382;TYR A 435;TRP A 528","58Y A 605 (-3.6A);58Y A 605 (-4.5A);58Y A 605 ( 4.2A);None;58Y A 605 (-3.3A);58Y A 605 (-4.9A);58Y A 605 ( 3.0A);None;58Y A 605 (-3.7A)","0.39A","2a3bA-5df0A:43.3","2a3bA-5df0A:27.63"],["2A3B_B_CFFB2435_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",9,"PHE A 181;GLY A 264;ASP A 303;GLU A 305;MET A 379;TYR A 381;ASP A 382;TYR A 435;TRP A 528","58Y A 605 (-4.5A);58Y A 605 ( 4.2A);None;58Y A 605 (-3.1A);58Y A 605 (-3.3A);58Y A 605 (-4.9A);58Y A 605 ( 3.0A);None;58Y A 605 (-3.7A)","0.63A","2a3bB-5df0A:12.2","2a3bB-5df0A:27.63"],["2A3C_A_PNXA1434_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",9,"TYR A 153;TRP A 157;PHE A 181;GLY A 264;ASP A 303;GLU A 305;MET A 379;TYR A 381;TRP A 528","58Y A 605 (-3.6A);None;58Y A 605 (-4.5A);58Y A 605 ( 4.2A);None;58Y A 605 (-3.1A);58Y A 605 (-3.3A);58Y A 605 (-4.9A);58Y A 605 (-3.7A)","0.69A","2a3cA-5df0A:12.2","2a3cA-5df0A:27.63"],["2A3C_A_PNXA1434_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",10,"TYR A 153;TRP A 157;PHE A 181;GLY A 264;ASP A 303;MET A 379;TYR A 381;ASP A 382;TYR A 435;TRP A 528","58Y A 605 (-3.6A);None;58Y A 605 (-4.5A);58Y A 605 ( 4.2A);None;58Y A 605 (-3.3A);58Y A 605 (-4.9A);58Y A 605 ( 3.0A);None;58Y A 605 (-3.7A)","0.41A","2a3cA-5df0A:12.2","2a3cA-5df0A:27.63"],["2A3C_B_PNXB2433_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",11,"TRP A 157;PHE A 181;GLY A 264;THR A 266;ASP A 303;GLU A 305;MET A 379;TYR A 381;ASP A 382;TYR A 435;TRP A 528","None;58Y A 605 (-4.5A);58Y A 605 ( 4.2A);SN5 A 604 (-3.1A);None;58Y A 605 (-3.1A);58Y A 605 (-3.3A);58Y A 605 (-4.9A);58Y A 605 ( 3.0A);None;58Y A 605 (-3.7A)","0.65A","2a3cB-5df0A:43.4","2a3cB-5df0A:27.63"],["2AOU_A_CQAA403_0","HISTAMINE N-METHYLTRANSFERASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"LYS A 240;GLY A 244;PHE A 296;ASP A 123","None","0.95A","2aouA-5df0A:undetectable","2aouA-5df0A:19.67"],["2AOU_A_CQAA403_0","HISTAMINE N-METHYLTRANSFERASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"LYS A 240;GLY A 244;PHE A 296;ASP A 125","None","0.93A","2aouA-5df0A:undetectable","2aouA-5df0A:19.67"],["2JKJ_D_CLMD1142_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"PRO A 270;PRO A 183;ILE A 182;GLY A 263","None","1.08A","2jkjD-5df0A:undetectable","2jkjD-5df0A:14.39"],["2JKJ_F_CLMF1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"PRO A 270;PRO A 183;ILE A 182;GLY A 263","None","1.08A","2jkjF-5df0A:undetectable","2jkjF-5df0A:14.39"],["2QHF_A_ACTA509_0","CHORISMATE SYNTHASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",3,"ARG A 206;GLN A 226;PRO A 221","None","0.89A","2qhfA-5df0A:undetectable","2qhfA-5df0A:21.48"],["2UY4_A_AZMA1311_1","ENDOCHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",6,"TYR A 153;PHE A 181;GLY A 264;ASP A 303;TYR A 381;TRP A 528","58Y A 605 (-3.6A);58Y A 605 (-4.5A);58Y A 605 ( 4.2A);None;58Y A 605 (-4.9A);58Y A 605 (-3.7A)","1.03A","2uy4A-5df0A:17.5","2uy4A-5df0A:21.21"],["2UY4_A_AZMA1311_1","ENDOCHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",6,"TYR A 153;PHE A 181;GLY A 264;GLU A 305;TYR A 381;TRP A 528","58Y A 605 (-3.6A);58Y A 605 (-4.5A);58Y A 605 ( 4.2A);58Y A 605 (-3.1A);58Y A 605 (-4.9A);58Y A 605 (-3.7A)","0.40A","2uy4A-5df0A:17.5","2uy4A-5df0A:21.21"],["2VE3_B_REAB1445_1","PUTATIVE CYTOCHROME P450 120","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"PHE A 484;ALA A 527;VAL A 514;GLY A 512;GLN A 489","None","1.29A","2ve3B-5df0A:undetectable","2ve3B-5df0A:21.82"],["2VN1_A_FK5A501_2","70 KDA PEPTIDYLPROLYL ISOMERASE;70 KDA PEPTIDYLPROLYL ISOMERASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"LEU A 256;SER A 261;ASP A 303;LYS A 257","None","1.14A","2vn1B-5df0A:undetectable","2vn1B-5df0A:12.50"],["2W1B_A_DXCA2034_0","ACRIFLAVIN RESISTANCE PROTEIN B","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",3,"PHE A 377;SER A 175;LEU A 177","None","0.68A","2w1bA-5df0A:undetectable","2w1bA-5df0A:20.43"],["2X45_A_HSMA1161_1","ALLERGEN ARG R 1","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"VAL A 517;TYR A 516;VAL A 415;SER A 380","None","1.23A","2x45A-5df0A:undetectable","2x45A-5df0A:11.72"],["2X45_B_HSMB1161_1","ALLERGEN ARG R 1","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"VAL A 517;TYR A 516;VAL A 415;SER A 380","None","1.22A","2x45B-5df0A:undetectable","2x45B-5df0A:11.72"],["2XCT_X_CPFX1020_1","DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"ARG A 471;GLY A 535;GLU A 138;SER A 509","None","1.38A","2xctS-5df0A:undetectable;2xctU-5df0A:undetectable","2xctS-5df0A:20.79;2xctU-5df0A:20.79"],["2XTK_A_AZMA1339_1","CLASS III CHITINASE CHIA1","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",6,"TYR A 153;PHE A 181;GLY A 264;GLU A 305;TYR A 381;TRP A 528","58Y A 605 (-3.6A);58Y A 605 (-4.5A);58Y A 605 ( 4.2A);58Y A 605 (-3.1A);58Y A 605 (-4.9A);58Y A 605 (-3.7A)","0.72A","2xtkA-5df0A:18.8","2xtkA-5df0A:21.17"],["2XTK_B_AZMB1339_1","CLASS III CHITINASE CHIA1","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"TYR A 153;PHE A 181;GLY A 264;ASP A 303;TYR A 381","58Y A 605 (-3.6A);58Y A 605 (-4.5A);58Y A 605 ( 4.2A);None;58Y A 605 (-4.9A)","1.16A","2xtkB-5df0A:18.9","2xtkB-5df0A:21.17"],["2XTK_B_AZMB1339_1","CLASS III CHITINASE CHIA1","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",6,"TYR A 153;PHE A 181;GLY A 264;GLU A 305;TYR A 381;TRP A 528","58Y A 605 (-3.6A);58Y A 605 (-4.5A);58Y A 605 ( 4.2A);58Y A 605 (-3.1A);58Y A 605 (-4.9A);58Y A 605 (-3.7A)","0.52A","2xtkB-5df0A:18.9","2xtkB-5df0A:21.17"],["2Y05_A_RALA801_1","PROSTAGLANDIN REDUCTASE 1;PROSTAGLANDIN REDUCTASE 1","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"VAL A  79;VAL A 119;TYR A  31;VAL A  93","None","1.02A","2y05A-5df0A:undetectable;2y05B-5df0A:undetectable","2y05A-5df0A:21.23;2y05B-5df0A:21.23"],["2ZZN_B_SAMB402_0","UNCHARACTERIZED PROTEIN MJ0883","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"PHE A 214;PHE A 290;ILE A 190;ASP A 192;PHE A 201","None","1.34A","2zznB-5df0A:undetectable","2zznB-5df0A:21.54"],["3ARQ_A_DM5A606_1","CHITINASE A","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",6,"TRP A 265;LYS A 360;ASP A 382;TRP A 387;TYR A 409;ARG A 437","NAG A 603 ( 3.9A);None;58Y A 605 ( 3.0A);NAG A 603 (-4.5A);None;58Y A 605 ( 3.3A)","0.79A","3arqA-5df0A:54.0","3arqA-5df0A:44.98"],["3ARR_A_PNXA606_1","CHITINASE A","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",7,"TRP A 265;GLY A 357;LYS A 360;ASP A 382;TRP A 387;TYR A 409;ARG A 437","NAG A 603 ( 3.9A);None;None;58Y A 605 ( 3.0A);NAG A 603 (-4.5A);None;58Y A 605 ( 3.3A)","0.71A","3arrA-5df0A:55.0","3arrA-5df0A:44.98"],["3ARR_A_PNXA607_1","CHITINASE A","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"SER A 200;HIS A 219;THR A 266;LEU A 267;TRP A 528","None;None;SN5 A 604 (-3.1A);None;58Y A 605 (-3.7A)","0.79A","3arrA-5df0A:55.0","3arrA-5df0A:44.98"],["3ARR_A_PNXA607_1","CHITINASE A","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"TRP A 157;SER A 200;HIS A 219;THR A 266;LEU A 267","None;None;None;SN5 A 604 (-3.1A);None","0.56A","3arrA-5df0A:55.0","3arrA-5df0A:44.98"],["3ARU_A_PNXA606_1","CHITINASE A","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",7,"PHE A 306;GLY A 357;LYS A 360;ASP A 382;TRP A 387;TYR A 409;ARG A 437","None;None;None;58Y A 605 ( 3.0A);NAG A 603 (-4.5A);None;58Y A 605 ( 3.3A)","0.75A","3aruA-5df0A:54.6","3aruA-5df0A:44.82"],["3ARU_A_PNXA608_1","CHITINASE A","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"TRP A 157;SER A 200;HIS A 219;ASP A 220","None","0.44A","3aruA-5df0A:54.6","3aruA-5df0A:44.82"],["3CCF_B_BEZB261_0","CYCLOPROPANE-FATTY-ACYL-PHOSPHOLIPID SYNTHASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"ILE A  47;TRP A 294;TYR A  43;ARG A 211","None;None;None;SO4 A 608 (-2.7A)","1.33A","3ccfB-5df0A:undetectable","3ccfB-5df0A:20.58"],["3G6M_A_CFFA1_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",11,"TYR A 153;PHE A 181;GLY A 264;TRP A 265;ASP A 303;GLU A 305;MET A 379;TYR A 381;ASP A 382;TYR A 435;TRP A 528","58Y A 605 (-3.6A);58Y A 605 (-4.5A);58Y A 605 ( 4.2A);NAG A 603 ( 3.9A);None;58Y A 605 (-3.1A);58Y A 605 (-3.3A);58Y A 605 (-4.9A);58Y A 605 ( 3.0A);None;58Y A 605 (-3.7A)","0.52A","3g6mA-5df0A:12.6","3g6mA-5df0A:28.23"],["3G6M_A_CFFA427_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"TRP A 265;MET A 379;ASP A 382;TRP A 387","NAG A 603 ( 3.9A);58Y A 605 (-3.3A);58Y A 605 ( 3.0A);NAG A 603 (-4.5A)","0.82A","3g6mA-5df0A:12.6","3g6mA-5df0A:28.23"],["3HS4_A_AZMA702_1","CARBONIC ANHYDRASE 2","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"VAL A 225;LYS A 240;TYR A  38;TRP A 294;GLU A  35","None","1.36A","3hs4A-5df0A:undetectable","3hs4A-5df0A:20.11"],["3MB5_A_SAMA301_1","SAM-DEPENDENT METHYLTRANSFERASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"GLY A 535;GLU A 138;ASP A 531;ASP A 536","None","1.15A","3mb5A-5df0A:undetectable","3mb5A-5df0A:19.05"],["3NXU_A_RITA600_1","CYTOCHROME P450 3A4","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"LEU A 171;ALA A 152;ILE A 541;ALA A 540;GLY A 143","None","0.98A","3nxuA-5df0A:undetectable","3nxuA-5df0A:22.15"],["3Q1E_C_T44C128_1","5-HYDROXYISOURATE HYDROLASE;5-HYDROXYISOURATE HYDROLASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"LEU A 171;LEU A 174;LEU A 259;LEU A 178","None","0.93A","3q1eA-5df0A:3.4;3q1eC-5df0A:undetectable","3q1eA-5df0A:12.55;3q1eC-5df0A:12.55"],["3Q1E_C_T44C128_1","5-HYDROXYISOURATE HYDROLASE;5-HYDROXYISOURATE HYDROLASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"LEU A 259;LEU A 178;LEU A 171;LEU A 174","None","0.86A","3q1eA-5df0A:3.4;3q1eC-5df0A:undetectable","3q1eA-5df0A:12.55;3q1eC-5df0A:12.55"],["3SJ0_X_DXCX75_0","CYTOCHROME C7","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"ILE A 182;PHE A 296;MET A 247;GLY A 244","None","1.10A","3sj0X-5df0A:undetectable","3sj0X-5df0A:11.72"],["3V3O_B_T1CB405_1","TETX2 PROTEIN","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"PHE A 306;ASN A 313;GLY A 309;GLY A 263;MET A 379","None;None;None;None;58Y A 605 (-3.3A)","1.18A","3v3oB-5df0A:undetectable","3v3oB-5df0A:21.33"],["3V8V_B_SAMB801_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE L","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"ASP A 533;ASP A 536;ASP A 505;VAL A 432;ASN A 173","None","1.26A","3v8vB-5df0A:undetectable","3v8vB-5df0A:22.27"],["3WQV_A_GCSA501_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"PHE A 181;GLY A 264;ASP A 303;TYR A 381;TRP A 528","58Y A 605 (-4.5A);58Y A 605 ( 4.2A);None;58Y A 605 (-4.9A);58Y A 605 (-3.7A)","0.97A","3wqvA-5df0A:42.2","3wqvA-5df0A:25.54"],["3WQV_A_GCSA501_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",10,"PHE A 181;GLY A 264;TRP A 265;GLU A 305;MET A 379;TYR A 381;ASP A 382;TYR A 435;ARG A 437;TRP A 528","58Y A 605 (-4.5A);58Y A 605 ( 4.2A);NAG A 603 ( 3.9A);58Y A 605 (-3.1A);58Y A 605 (-3.3A);58Y A 605 (-4.9A);58Y A 605 ( 3.0A);None;58Y A 605 ( 3.3A);58Y A 605 (-3.7A)","0.52A","3wqvA-5df0A:42.2","3wqvA-5df0A:25.54"],["3WQW_A_GCSA501_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"PHE A 181;GLY A 264;ASP A 303;TYR A 381;TRP A 528","58Y A 605 (-4.5A);58Y A 605 ( 4.2A);None;58Y A 605 (-4.9A);58Y A 605 (-3.7A)","0.99A","3wqwA-5df0A:42.2","3wqwA-5df0A:25.54"],["3WQW_A_GCSA501_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",10,"PHE A 181;GLY A 264;TRP A 265;GLU A 305;MET A 379;TYR A 381;ASP A 382;TYR A 435;ARG A 437;TRP A 528","58Y A 605 (-4.5A);58Y A 605 ( 4.2A);NAG A 603 ( 3.9A);58Y A 605 (-3.1A);58Y A 605 (-3.3A);58Y A 605 (-4.9A);58Y A 605 ( 3.0A);None;58Y A 605 ( 3.3A);58Y A 605 (-3.7A)","0.56A","3wqwA-5df0A:42.2","3wqwA-5df0A:25.54"],["4FGK_A_0TXA302_0","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"PHE A 283;ILE A 182;PRO A 183;PHE A 271","None","1.04A","4fgkA-5df0A:undetectable","4fgkA-5df0A:17.55"],["4J4V_B_SVRB301_1","NUCLEOCAPSID PROTEIN","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"GLY A 461;ARG A 162;ALA A 532;VAL A 468;PRO A 458","None","1.36A","4j4vB-5df0A:0.4","4j4vB-5df0A:18.54"],["4LRH_B_FOLB301_1","FOLATE RECEPTOR ALPHA","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",3,"ASP A 359;TRP A 265;SER A 355","None;NAG A 603 ( 3.9A);None","0.89A","4lrhB-5df0A:undetectable","4lrhB-5df0A:17.60"],["4LRH_F_FOLF301_1","FOLATE RECEPTOR ALPHA","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",3,"ASP A 359;TRP A 265;SER A 355","None;NAG A 603 ( 3.9A);None","0.86A","4lrhF-5df0A:undetectable","4lrhF-5df0A:17.60"],["4N09_B_ADNB401_2","ADENOSINE KINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"LEU A 171;SER A 175;LEU A 538;ASN A 542","None","1.04A","4n09B-5df0A:4.0","4n09B-5df0A:22.78"],["4N09_C_ADNC401_2","ADENOSINE KINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"LEU A 171;SER A 175;LEU A 538;ASN A 542","None","1.03A","4n09C-5df0A:undetectable","4n09C-5df0A:22.78"],["4WBO_B_ANWB601_0","RHODOPSIN KINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"LEU A 177;ALA A 152;ILE A 530;ALA A 249","None","0.69A","4wboB-5df0A:undetectable","4wboB-5df0A:22.76"],["4XNX_A_41XA707_1","TRANSPORTER","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"ASP A 359;ALA A 323;VAL A 364;TYR A 366;GLY A 309","None","1.07A","4xnxA-5df0A:undetectable","4xnxA-5df0A:21.84"],["4XP9_C_1WEC706_1","TRANSPORTER","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"PHE A 181;ASP A 301;GLY A 264;SER A 261","58Y A 605 (-4.5A);None;58Y A 605 ( 4.2A);None","1.41A","4xp9C-5df0A:undetectable","4xp9C-5df0A:21.51"],["5EF8_B_LBHB2004_1","HDAC6 PROTEIN","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"ASP A 188;HIS A 275;PHE A 273;ASP A 322;LEU A 316","None","1.42A","5ef8B-5df0A:undetectable","5ef8B-5df0A:20.60"],["5GQB_A_GCSA602_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",3,"TRP A 265;GLU A 305;ASP A 382","NAG A 603 ( 3.9A);58Y A 605 (-3.1A);58Y A 605 ( 3.0A)","0.17A","5gqbA-5df0A:62.6","5gqbA-5df0A:61.01"],["5GQB_A_GCSA603_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",8,"PHE A 181;GLY A 264;TRP A 265;GLU A 305;TYR A 381;ASP A 382;ARG A 437;TRP A 528","58Y A 605 (-4.5A);58Y A 605 ( 4.2A);NAG A 603 ( 3.9A);58Y A 605 (-3.1A);58Y A 605 (-4.9A);58Y A 605 ( 3.0A);58Y A 605 ( 3.3A);58Y A 605 (-3.7A)","0.39A","5gqbA-5df0A:62.6","5gqbA-5df0A:61.01"],["5GQB_A_GCSA604_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"TRP A 157;TRP A 265;THR A 266;LEU A 267","None;NAG A 603 ( 3.9A);SN5 A 604 (-3.1A);None","0.36A","5gqbA-5df0A:62.6","5gqbA-5df0A:61.01"],["5GQB_A_GCSA605_1","CHITINASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",3,"TRP A 157;ILE A 197;SER A 200","None","0.68A","5gqbA-5df0A:62.6","5gqbA-5df0A:61.01"],["5K9D_A_ACTA407_0","DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"ASP A  54;THR A  90;GLN A  56;ARG A  88","None;SO4 A 609 (-3.8A);None;None","1.32A","5k9dA-5df0A:12.2","5k9dA-5df0A:22.30"],["5LJC_A_RTLA201_0","RETINOL-BINDING PROTEIN 1","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"ALA A 369;LEU A 373;SER A 352;ILE A 361;LEU A 522","None","1.12A","5ljcA-5df0A:undetectable","5ljcA-5df0A:15.07"],["5VOO_A_C2FA3001_0","5-METHYLTETRAHYDROFOLATE HOMOCYSTEINE S-METHYLTRANSFERASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"GLU A 529;ARG A 162;GLY A 158;LEU A 256;ILE A 530","SN5 A 604 (-3.9A);None;None;None;None","1.16A","5vooA-5df0A:3.1","5vooA-5df0A:21.07"],["5VOO_C_C2FC702_0","5-METHYLTETRAHYDROFOLATE HOMOCYSTEINE S-METHYLTRANSFERASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"GLU A 529;ARG A 162;GLY A 158;LEU A 256;ILE A 530","SN5 A 604 (-3.9A);None;None;None;None","1.14A","5vooC-5df0A:4.2","5vooC-5df0A:21.07"],["6DWN_C_AQ4C602_1","CYTOCHROME P450 1A1","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",3,"SER A 207;SER A 203;ALA A 223","None","0.52A","6dwnC-5df0A:undetectable","6dwnC-5df0A:9.83"],["6F6S_B_CXQB705_1","ENVELOPE GLYCOPROTEIN,ENVELOPE GLYCOPROTEIN,GP1;ENVELOPE GLYCOPROTEIN","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",4,"VAL A 169;LEU A 174;LEU A 256;LEU A 178","None","0.87A","6f6sA-5df0A:undetectable;6f6sB-5df0A:undetectable","6f6sA-5df0A:10.49;6f6sB-5df0A:11.95"],["6R2E_F_FFOF403_0","THYMIDYLATE SYNTHASE","5df0","AC-CHIA","Autographa californica multiple nucleopolyhedrovirus",5,"LEU A 174;ASP A 533;LEU A 537;GLY A 535;ALA A 527","None","1.32A","6r2eF-5df0A:undetectable","6r2eF-5df0A:20.33"]]